|
ATHE Alterity Therapeutics Ltd 1131343 |
| Income Statement |
|
Net Income
|
2025-06-30
|
$-12,147,828.00 |
| Balance Sheet |
|
Current Assets
|
$45,871,186.00 |
|
Assets
|
$46,026,360.00 |
|
Current Liabilities
|
$3,534,729.00 |
|
Liabilities
|
$3,623,274.00 |
|
Equity
|
$42,403,086.00 |
|
Shares Out
|
9127370686.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,451,248.00 |
|
Investing Cash Flow
|
$-7,500,000.00 |
| Market Analysis |
Market Cap
|
$41,073,168,087.00 |
|
Price
|
$4.42 |
|
PB
|
25.85 |
|
EPS
|
-0.01 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:36 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATHE documents filed with the SEC.
ATHE Filings
Clear
